On the other hand, a natural compound, thymoquinone, decreased the levels of key hypertrophic markers, ANP and BNP, and reduced type 1 collagen expression in angiotensin II (AngII)-treated H9c2 cells and TAC mice, consequently mitigating cardiac hypertrophy. This evidence concerns the gene AGT and cardiac hypertrophy.